Ocular Therapeutix Q3 EPS $(0.42) Misses $(0.36) Estimate, Sales $12.874M Miss $14.339M Estimate
Benzinga Newsdesk 4 hours ago
NewsEarningsEarnings Misses
Ocular Therapeutix (NASDAQ:OCUL) reported quarterly losses of $(0.42) per share which missed the analyst consensus estimate of $(0.36) by 16.67 percent. This is a 10.53 percent decrease over losses of $(0.38) per share
Ocular Therapeutix (NASDAQ:OCUL) reported quarterly losses of $(0.42) per share which missed the analyst consensus estimate of $(0.36) by 16.67 percent. This is a 10.53 percent decrease over losses of $(0.38) per share from the same period last year. The company reported quarterly sales of $12.874 million which missed the analyst consensus estimate of $14.339 million by 10.22 percent. This is a 11.48 percent decrease over sales of $14.544 million the same period last year.